FDA approves extract for house dust mite allergic rhinitis

On March 1, the U.S. Food and Drug Administration (FDA) approved Odactra, the first allergen extract to be administered sublingually to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in people 18 through 65 years of age. Read more


Please enter your comment!
Please enter your name here